Notice for trientine tetrahydrochloride (JACE Pharma Pty Ltd)
Active ingredients
trientine tetrahydrochloride
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
Treatment of Wilson's Disease
Therapeutic area
Inherited metabolic disorders